Volume 34, Issue 10 2014 pp. 2418-2425
Article

Does Pringle Maneuver Affect Survival in Patients with Colorectal Liver Metastases?

Alessandro Ferrero

Corresponding Author

Alessandro Ferrero

Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati, 62-10128 Turin, Italy

[email protected]Search for more papers by this author
Nadia Russolillo

Nadia Russolillo

Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati, 62-10128 Turin, Italy

Search for more papers by this author
Luca Viganò

Luca Viganò

Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati, 62-10128 Turin, Italy

Search for more papers by this author
Roberto Lo Tesoriere

Roberto Lo Tesoriere

Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati, 62-10128 Turin, Italy

Search for more papers by this author
Andrea Muratore

Andrea Muratore

Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati, 62-10128 Turin, Italy

Search for more papers by this author
Lorenzo Capussotti

Lorenzo Capussotti

Department of Surgery, Ospedale Mauriziano “Umberto I”, Largo Turati, 62-10128 Turin, Italy

Search for more papers by this author
First published: 18 June 2010
Citations: 33

Abstract

Background

The purpose of this original article was to evaluate the impact of the Pringle maneuver on the survival of patients with colorectal liver metastases.

Methods

Eighty patients with colorectal liver metastases were randomized to undergo hepatectomy with (39 patients, HPC group) or without (41 patients, NHPC group) pedicle clamping.

Results

The two groups were homogeneous. Mortality and morbidity rates were similar. Blood transfusions rates were higher in HPC group (p = 0.010). Median follow-up was 67.1 ± 20 months in the HPC group and 77.5 ± 16.6 months in the other group (p = 0.07). Overall survival at 1, 3, and 5 years was 100%, 86.1%, and 49.4% in HPC group vs. 92.6%, 65.8%, and 48.2% in NHPC group (p = 0.704). Disease-free survival was similar between the two groups: 1-, 3- and 5-year survival rates were 85.7%, 51.4%, and 34.3% in the HPC group vs. 84%, 51.5%, and 37.9% in NHPC group (p = 0.943). The incidence of hepatic recurrence was similar in the two groups (p = 0.506). Median time to hepatic recurrence was similar in the two groups (p = 0.482). Overall and disease-free survival rates were similar even when the Pringle maneuver was longer than 45 min (p = 0.571 and 0.948) and in patients with liver steatosis (p = 0.779 and 0.412).

Conclusions

The Pringle maneuver does not seem to affect the survival of patients with liver metastases.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.